While delivering remarkable benefits for patients, the biopharmaceutical industry continues to experience pressure to accelerate timelines, increase flexibility to address multiple-product manufacturing and/ or market demand, and significantly reduce the manufacturing cost of goods. Intensified processing is one approach that is being used to successfully address these challenges by increasing speed, reducing plant footprint, and improving productivity without compromising product quality.
In this white paper, we explore perfusion processes and how they are becoming a viable solution.